HELE,TXMD Stock Price and Quote

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: PG JNJ CL EL CLX NWL CHD TPR KMB HSY

| Held by: VTI IWM FNDA VXF IWN SCHA VTWO VCR VFVA DFSV

Index	RUT	P/E	-	EPS (ttm)	-34.51	Insider Own	1.84%	Shs Outstand	23.05M	Perf Week	-7.33%
Market Cap	404.11M	Forward P/E	5.18	EPS next Y	3.38	Insider Trans	0.00%	Shs Float	22.65M	Perf Month	-10.32%
Enterprise Value	1.32B	PEG	-	EPS next Q	0.75	Inst Own	93.07%	Short Float	10.11%	Perf Quarter	-8.15%
Income	-792.50M	P/S	0.22	EPS this Y	-51.58%	Inst Trans	-11.83%	Short Ratio	2.59	Perf Half Y	-24.08%
Sales	1.81B	P/B	0.47	EPS next Y	-2.59%	ROA	-29.83%	Short Interest	2.29M	Perf YTD	-17.58%
Book/sh	36.98	P/C	13.59	EPS next 5Y	-	ROE	-63.90%	52W High	60.42 -71.01%	Perf Year	-69.02%
Cash/sh	1.29	P/FCF	7.23	EPS past 3/5Y	-16.35% -2.26%	ROIC	-44.63%	52W Low	16.29 7.52%	Perf 3Y	-84.99%
Dividend Est.	-	EV/EBITDA	6.53	Sales past 3/5Y	-5.03% 2.23%	Gross Margin	46.81%	Volatility	5.70% 5.76%	Perf 5Y	-92.09%
Dividend TTM	-	EV/Sales	0.73	EPS Y/Y TTM	-793.02%	Oper. Margin	8.22%	ATR (14)	1.06	Perf 10Y	-80.66%
Dividend Ex-Date	-	Quick Ratio	0.90	Sales Y/Y TTM	-5.54%	Profit Margin	-43.90%	RSI (14)	43.50	Recom	2.50
Dividend Gr. 3/5Y	- -	Current Ratio	1.81	EPS Q/Q	-268.29%	SMA20	-2.49%	Beta	0.79	Target Price	28.00
Payout	0.00%	Debt/Eq	1.11	Sales Q/Q	-2.99%	SMA50	-10.00%	Rel Volume	0.82	Prev Close	17.64
Employees	1883	LT Debt/Eq	1.08	Earnings	Jan 08 BMO	SMA200	-23.45%	Avg Volume	883.13K	Price	17.51
IPO	Mar 18, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	0.66% 1.68%	Trades		Volume	290,735	Change	-0.71%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-11-25	Downgrade	Canaccord Genuity	Buy → Hold	$26
Jul-10-24	Downgrade	DA Davidson	Buy → Neutral	$139 → $67
Apr-17-23	Initiated	UBS	Neutral	$99
Dec-22-22	Upgrade	DA Davidson	Neutral → Buy	$115 → $126
Nov-17-22	Initiated	Canaccord Genuity	Buy	$120
Jul-13-22	Initiated	Raymond James	Mkt Perform
Feb-07-22	Upgrade	Sidoti	Neutral → Buy	$263
Mar-17-21	Downgrade	DA Davidson	Buy → Neutral	$247
Jan-28-21	Downgrade	Oppenheimer	Outperform → Perform
Jan-08-21	Downgrade	BofA Securities	Buy → Neutral	$235
Feb-06-20	Initiated	Oppenheimer	Outperform
Jul-10-19	Reiterated	BofA/Merrill	Buy	$160 → $165
May-08-19	Downgrade	Sidoti	Buy → Neutral
Jul-10-18	Upgrade	BofA/Merrill	Neutral → Buy	$127
Mar-29-18	Initiated	DA Davidson	Buy	$100
Sep-12-17	Initiated	CL King	Buy	$104
Aug-29-17	Initiated	BofA/Merrill	Underperform	$87
Dec-07-16	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-19-16	Upgrade	Sidoti	Neutral → Buy
Mar-07-16	Initiated	Jefferies	Buy

Show Previous Ratings

Feb-02-26 05:45AM	Zacks Value Trader Highlights: Whirlpool, The Estee Lauder Companies, Deckers Outdoor, Pool and Helen of Troy (Zacks) +7.73%
Jan-30-26 07:10PM	5 Beaten Down Stocks: Deals or Traps? (Zacks)
11:02AM	Is Estee Lauder Stock Worth Buying Ahead of Q2 Earnings Release? (Zacks)
Jan-26-26 09:01AM	Hydro Flask Partners with Ocean Conservancy, Joining Protect Where We Play Movement (PR Newswire)
Jan-15-26 02:19PM	UBS Retains a Neutral Rating on Helen of Troy Limited (HELE) (Insider Monkey)
09:05AM	Loading…
Jan-14-26 09:05AM	Estee Lauder Stock Rises 21.9% in 3 Months: What Should Investors Do? (Zacks)
Jan-13-26 05:00AM	Inspire appoints Matt Osberg as CFO (MedTech Dive)
Jan-09-26 08:04AM	HELE Q3 Earnings Meet Estimates, Home & Outdoor Sales Decline Y/Y (Zacks) -5.74%
Jan-08-26 04:00PM	Helen Of Troy Ltd (HELE) Q3 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
10:39AM	Helen of Troy Q3 Earnings Call Highlights (MarketBeat)
10:24AM	Helen Of Troy Flags Tariff Pain, Cuts Outlook (Benzinga)
09:30AM	Helen of Troy (HELE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:53AM	Helen of Troy: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Helen of Troy Limited Reports Third Quarter Fiscal 2026 Results (Business Wire)
Jan-02-26 10:37AM	Helen of Troy Q3 Earnings on Deck: Key Factors You Should Understand (Zacks)
08:44AM	Loading…
Dec-31-25 08:44AM	Implied Volatility Surging for Helen of Troy Stock Options (Zacks)
Dec-29-25 06:21AM	Zacks Industry Outlook Highlights Estee Lauder, Coty, Helen of Troy and European Wax Center (Zacks)
Dec-26-25 09:31AM	4 Cosmetics Stocks to Watch as the Market Resets for 2026 (Zacks)
Dec-22-25 04:05PM	Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Third Quarter Fiscal Year 2026 Results (Business Wire)
Dec-05-25 05:49PM	CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Nov-25-25 05:45PM	Helen of Troy Limited Announces Amendment to Existing Credit Agreement (Business Wire)
Nov-24-25 09:12AM	Are Options Traders Betting on a Big Move in Helen of Troy Stock? (Zacks)
Nov-05-25 06:30AM	Novo Nordisks $10 Billion Bid Ups the Ante in Bidding War for Obesity Biotech Metsera (The Daily Upside)
Oct-28-25 12:52PM	Arbor Snowboards and Hydro Flask Announce Multi-Year Collaboration (PR Newswire)
Oct-27-25 08:33AM	Lam Research and Helen of Troy have been highlighted as Zacks Bull and Bear of the Day (Zacks)
06:10AM	Bear of the Day: Helen of Troy (HELE) (Zacks)
Oct-24-25 08:46AM	Is the Options Market Predicting a Spike in Helen of Troy Stock? (Zacks)
Oct-20-25 09:30AM	Estee Lauder Targets 25% of Sales From Innovation in Fiscal 2026 (Zacks)
Oct-13-25 09:00AM	Revlon Unveils New 3-In-One One-Step Multi-Styler For Salon-Quality Hair At Home (PR Newswire) -5.29%
Oct-10-25 01:12PM	Helen of Troy Q2 Earnings Beat Estimates, Sales Decline 9% Y/Y (Zacks)
03:00PM	Loading…
Oct-09-25 03:00PM	Helen Of Troy Ltd (HELE) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com) -24.99%
09:30AM	Helen of Troy (HELE) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:00AM	Helen of Troy (HELE) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:57AM	Helen of Troy: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
06:45AM	Helen of Troy Limited Reports Second Quarter Fiscal 2026 Results (Business Wire)
Oct-08-25 09:17AM	What To Expect From Helen Of Troy Ltd (HELE) Q2 2026 Earnings (GuruFocus.com)
Oct-07-25 09:09AM	Zacks Industry Outlook Highlights The Estee Lauder, e.l.f. Beauty, Helen of Troy and European Wax Center (Zacks)
08:46AM	Helen of Troy Gears Up for Q2 Earnings: Here's What You Should Know (Zacks)
Oct-06-25 09:26AM	4 Cosmetics Leaders Adapting and Thriving Despite Industry Pressures (Zacks)
09:15AM	Exploring Analyst Estimates for Helen of Troy (HELE) Q2 Earnings, Beyond Revenue and EPS (Zacks)
Oct-02-25 02:39PM	How to make money from tax-loss selling between now and the end of the year (MarketWatch)
Sep-18-25 04:05PM	Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal Year 2026 Results (Business Wire)
Sep-02-25 11:04AM	OXO Announces 2025 Chefs in Residence: Fariyal Abdullahi and Danielle Sepsy Join for a New Season Inspired by Bold Flavors and Heritage (PR Newswire)
Sep-01-25 09:35AM	Prosper Stars & Stripes Exited Helen of Troy Limited (HELE) After Achieving Solid Returns (Insider Monkey)
Aug-21-25 11:29AM	Implied Volatility Surging for Helen of Troy Stock Options (Zacks) -5.09%
Aug-14-25 09:08AM	El Paso's Helen of Troy names Scott Uzzell, former Nike, Coca-Cola executive, as new CEO (The El Paso Times)
Aug-13-25 04:05PM	Helen of Troy Limited Announces G. Scott Uzzell Appointed to Become Chief Executive Officer (Business Wire)
09:01AM	Osprey Packs Introduces Its Most Advanced Run Collection Yet for Spring 2026 (PR Newswire)
Aug-12-25 09:10AM	UBS Lowers PT on Helen of Troy Limited (HELE) to $29 From $32, Keeps a Neutral Rating (Insider Monkey) +5.22%
09:01AM	Osprey Packs's Newest Bike Collection Creates Carry Solutions for Every Rider (PR Newswire)
05:35AM	Hydro Flask, Osprey owner doubles down on Southeast Asia sourcing (Supply Chain Dive)
Aug-11-25 09:01AM	Osprey Packs Prioritizes Fit, Quality Suspension and Carrying Comfort for Spring 2026 Hike Collection (PR Newswire)
Aug-05-25 11:41AM	Should You Buy or Hold SharkNinja Stock Before Q2 Earnings? (Zacks)
Jul-30-25 11:00AM	Is EWCZ Fixing Its Overbuilt Network With Smarter Expansion? (Zacks)
Jul-16-25 09:42AM	EWCZ Stock Skyrockets 54% in 3 Months: Is it Too Late to Buy? (Zacks) +11.67%
Jul-15-25 10:55AM	EWCZ EBITDA Expansion Shows Early Wins: Can Margins Stay Strong? (Zacks) -7.65%
Jul-11-25 11:13AM	Helen of Troy Q1 Earnings Fall Short of Estimates, Sales Dip Y/Y (Zacks) -5.88%
10:02AM	EWCZ Marketing Shift Shows Early Wins: Can Growth Reignite Fast? (Zacks)
03:01AM	Helen Of Troy Ltd (HELE) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Jul-10-25 04:53PM	These Stocks Moved the Most Today: Nvidia, Delta, WK Kellogg, MP Materials, Vertiv, Helen of Troy, and More (Barrons.com) -22.71%
03:50PM	Helen of Troy (HELE) Misses Q1 Earnings and Revenue Estimates (Zacks)
03:29PM	Inflation from tariffs should hit this year, consumer-brands company says (MarketWatch)
02:26PM	These Stocks Are Moving the Most Today: Nvidia, Delta, WK Kellogg, MP Materials, Vertiv, Helen of Troy, and More (Barrons.com)
10:38AM	Helen of Troy Stock Sinks as Firm Posts Slowing Sales, Rues Tariff Impacts (Investopedia)
07:55AM	Helen of Troy (HELE) Q1 Earnings and Revenues Miss Estimates (Zacks)
06:54AM	Helen of Troy: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
06:45AM	Helen of Troy Limited Reports First Quarter Fiscal 2026 Results (Business Wire)
Jul-09-25 06:22PM	Markets Rally Ahead Despite Potential Complications (Zacks)
09:19AM	Helen Of Troy Ltd (HELE) Q1 2026: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-04-25 09:15AM	Stay Ahead of the Game With Helen of Troy (HELE) Q1 Earnings: Wall Street's Insights on Key Metrics (Zacks)
08:56AM	Helen of Troy Q1 Earnings Coming Up: What Investors Need to Know (Zacks)
Jun-23-25 06:45AM	Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal Year 2026 Results (Business Wire)
Jun-13-25 08:48AM	Are Options Traders Betting on a Big Move in Helen of Troy Stock? (Zacks)
Jun-09-25 11:38AM	Helen of Troy Limited (HELE): A Bull Case Theory (Insider Monkey)
Jun-05-25 11:30AM	Why Is Coty (COTY) Up 9% Since Last Earnings Report? (Zacks)
May-08-25 09:21AM	Agnico Eagle Mines and Helen of Troy have been highlighted as Zacks Bull and Bear of the Day (Zacks) +9.23%
06:23AM	Bear of the Day: Helen of Troy (HELE) (Zacks)
May-07-25 08:23AM	Helen of Troy CEO out after 14 months (Retail Dive)
May-05-25 04:57PM	Why Helen of Troy Stock Plunged Today (Motley Fool) -10.35%
May-03-25 10:24PM	The 1-Minute Market Report May 4, 2025 (Seeking Alpha)
May-02-25 04:18PM	Helen of Troy Announces CEO Leadership Change (Business Wire) -10.35%
Apr-28-25 10:25AM	The 1-Minute Market Report April 27, 2025 (Seeking Alpha)
Apr-25-25 10:42AM	Helen of Troy Shares Down on Q4 Earnings Miss, Sales Decline Y/Y (Zacks)
Apr-24-25 01:24PM	Helen of Troy Limited (HELE) Q4 2025 Earnings Call Transcript (Seeking Alpha) -11.96%
09:30AM	Compared to Estimates, Helen of Troy (HELE) Q4 Earnings: A Look at Key Metrics (Zacks)
07:55AM	Helen of Troy (HELE) Misses Q4 Earnings Estimates (Zacks)
07:02AM	Helen of Troy: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
06:45AM	Helen of Troy Limited Reports Fourth Quarter Fiscal 2025 Results (Business Wire)
Apr-22-25 12:10PM	Why Helen of Troy (HELE) Could Beat Earnings Estimates Again (Zacks) +5.58%
Apr-21-25 10:06AM	Helen of Troy Gears Up for Q4 Earnings: Key Factors to Note (Zacks) -5.34%
Apr-19-25 03:41PM	Is Helen of Troy Limited (HELE) the Ridiculously Cheap Stock to Invest in? (Insider Monkey)
Apr-14-25 10:09AM	4 Cosmetic Stocks to Keep an Eye On Despite Market Challenges (Zacks)
Apr-10-25 09:44AM	Helen of Troy (HELE) Soars 10.3%: Is Further Upside Left in the Stock? (Zacks) -11.96%
Apr-03-25 04:05PM	Helen of Troy Limited Announces Earnings Release Date, Conference Call, and Webcast for Fourth Quarter and Fiscal Year 2025 Results (Business Wire) -13.11%
11:47AM	Walmart, Costco Are Consumer Stocks to Consider After Trump Tariffs, Oppenheimer Says (Investopedia)
Mar-25-25 01:10PM	Why Helen of Troy Limited (HELE) is Among the Best Household Stocks to Buy According to Hedge Funds (InsiderMonkey)
Mar-24-25 09:15AM	Is Helen of Troy Ltd. (HELE) the Best Small-Cap Value Stock to Buy Now? (InsiderMonkey)
Mar-22-25 01:07AM	Helen Of Troy: Return To Growth, Cost-Saving Actions, And Low Valuations Make It A Good Buy (SeekingAlpha)
Mar-19-25 11:40AM	HELE vs. ELF: Which Stock Should Value Investors Buy Now? (Zacks)
Mar-17-25 09:40AM	Is Helen of Troy (HELE) a Great Value Stock Right Now? (Zacks)

Helen of Troy Ltd. operates as a global consumer products company offering creative products and solutions for its customers. It offers its services through brands including OXO, Hydro Flask, Osprey, Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon, and Olive & June. The firm operates through the Home and Outdoor, and Beauty and Wellness segments. The Home and Outdoor segment offers food preparation tools, containers, electronics, baby care, and cleaning products. The Beauty and Wellness segment develops and provides products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans. The company was founded by Gerald J. Rubin and Stanlee N. Rubin in 1968 and is headquartered in Hamilton, Bermuda.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
JUDGE TESSA	Chief Legal Officer	Jul 16 '25	Buy	22.87	435	9,948	24,812	Jul 16 07:19 PM
Grass Brian	Chief Executive Officer	Jul 15 '25	Buy	21.47	10,000	214,700	135,932	Jul 15 06:38 PM
SCHEUERMAN TRACY	Chief Financial Officer	Jul 15 '25	Buy	20.13	10,000	201,300	33,041	Jul 15 06:38 PM

TXMD TherapeuticsMD Inc daily Stock Chart

Peers: VERU SNDX ARCT TGTX ONCY ATNM VRCA IBRX HRTG GNPX

| Held by: VTI VXF

Index	-	P/E	90.23	EPS (ttm)	0.03	Insider Own	1.62%	Shs Outstand	11.57M	Perf Week	-5.04%
Market Cap	27.26M	Forward P/E	-	EPS next Y	-	Insider Trans	4.69%	Shs Float	11.39M	Perf Month	5.13%
Enterprise Value	26.62M	PEG	-	EPS next Q	-	Inst Own	29.29%	Short Float	0.42%	Perf Quarter	45.37%
Income	0.30M	P/S	9.74	EPS this Y	-	Inst Trans	1.19%	Short Ratio	0.42	Perf Half Y	101.30%
Sales	2.80M	P/B	0.99	EPS next Y	-	ROA	0.19%	Short Interest	0.05M	Perf YTD	44.48%
Book/sh	2.37	P/C	3.83	EPS next 5Y	-	ROE	0.27%	52W High	2.95 -20.17%	Perf Year	128.64%
Cash/sh	0.62	P/FCF	13.17	EPS past 3/5Y	79.41% 64.95%	ROIC	0.92%	52W Low	0.72 227.08%	Perf 3Y	-55.31%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-11.87% -48.72%	Gross Margin	86.16%	Volatility	8.70% 11.55%	Perf 5Y	-97.45%
Dividend TTM	-	EV/Sales	9.51	EPS Y/Y TTM	109.08%	Oper. Margin	-93.71%	ATR (14)	0.21	Perf 10Y	-99.27%
Dividend Ex-Date	-	Quick Ratio	2.46	Sales Y/Y TTM	75.19%	Profit Margin	10.80%	RSI (14)	54.09	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.46	EPS Q/Q	124.81%	SMA20	-1.23%	Beta	0.49	Target Price	5.00
Payout	-	Debt/Eq	0.24	Sales Q/Q	43.33%	SMA50	14.91%	Rel Volume	0.13	Prev Close	2.36
Employees	1	LT Debt/Eq	0.20	Earnings	Nov 12 AMC	SMA200	63.58%	Avg Volume	114.48K	Price	2.36
IPO	Jan 03, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	6,117	Change	-0.21%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-20	Downgrade	Jefferies	Hold → Underperform
May-19-20	Downgrade	JP Morgan	Overweight → Neutral
Dec-02-19	Initiated	Guggenheim	Buy
Oct-17-19	Initiated	H.C. Wainwright	Buy	$7
Apr-30-19	Resumed	Noble Capital Markets	Outperform	$13
Jun-15-18	Initiated	JP Morgan	Overweight	$11
Sep-08-17	Initiated	Morgan Stanley	Equal-Weight	$6
Jul-11-17	Upgrade	Oppenheimer	Perform → Outperform
May-09-17	Downgrade	Oppenheimer	Outperform → Perform
Nov-22-16	Resumed	Jefferies	Buy	$18
Nov-22-16	Initiated	Oppenheimer	Outperform
Nov-07-16	Resumed	Guggenheim	Buy
Apr-04-16	Initiated	Goldman	Buy	$10
Dec-08-15	Reiterated	Stifel	Buy	$10 → $14
Dec-08-15	Reiterated	Jefferies	Buy	$15 → $18
Sep-21-15	Reiterated	Jefferies	Buy	$7 → $15
Jun-09-15	Initiated	Guggenheim	Buy
Jul-08-14	Initiated	FBR Capital	Outperform	$34
Apr-17-14	Reiterated	Noble Financial	Buy	$9 → $13
Jan-28-14	Reiterated	Noble Financial	Buy	$7.25 → $9

Show Previous Ratings

Nov-12-25 06:04PM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces Third Quarter 2025 Financial Results (Business Wire)
Aug-12-25 04:47PM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces Second Quarter 2025 Financial Results (Business Wire)
May-13-25 05:02PM	TherapeuticsMD: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	TherapeuticsMD Announces First Quarter 2025 Financial Results (Business Wire)
Mar-27-25 04:05PM	TherapeuticsMD Announces Full Year 2024 Financial Results (Business Wire) -6.48%
Nov-12-24 04:32PM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces Third Quarter 2024 Financial Results (Business Wire)
Aug-12-24 05:26PM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces Second Quarter 2024 Financial Results (Business Wire)
Jun-28-24 11:52AM	TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023 (InvestorPlace) -7.47%
May-10-24 08:53PM	TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024 (InvestorPlace)
04:43PM	TherapeuticsMD: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	TherapeuticsMD Announces First Quarter 2024 Financial Results (Business Wire)
04:00PM	Loading…
Mar-29-24 04:00PM	TherapeuticsMD Announces Full Year 2023 Financial Results (Business Wire)
Mar-12-24 11:40AM	25 Countries With Highest Abortion Rates (Insider Monkey) +6.95%
Jan-30-24 11:20PM	12 Best Prenatal Vitamins For Pregnant Women (Insider Monkey)
Nov-15-23 05:08AM	TherapeuticsMD: Q3 Earnings Snapshot (Associated Press Finance) +17.41%
Nov-14-23 04:05PM	TherapeuticsMD Announces Third Quarter 2023 Financial Results (Business Wire)
Aug-14-23 07:52AM	TherapeuticsMD: Q2 Earnings Snapshot (Associated Press Finance)
06:50AM	TherapeuticsMD Announces Second Quarter 2023 Financial Results (Business Wire)
May-15-23 05:56PM	TherapeuticsMD: Q1 Earnings Snapshot (AP Finance)
04:05PM	TherapeuticsMD Announces First Quarter 2023 Financial Results (Business Wire)
Apr-14-23 12:00PM	All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy (Zacks)
Apr-07-23 04:01PM	TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition (Business Wire)
Jan-03-23 06:50AM	TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma (Business Wire) +11.81%
Dec-08-22 10:42AM	Boca pharma company will cut 212 employees after failed buyout (American City Business Journals)
Dec-04-22 06:00PM	TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma (Business Wire)
Nov-14-22 07:55PM	TherapeuticsMD (TXMD) Reports Q3 Loss, Lags Revenue Estimates (Zacks) -7.45% -8.20%
04:05PM	Loading…
04:05PM	TherapeuticsMD Announces Third Quarter 2022 Financial Results (Business Wire)
Oct-31-22 06:50AM	TherapeuticsMD Announces Additional $7 Million Private Placement (Business Wire) +6.21%
Oct-03-22 01:45PM	TherapeuticsMD receives $7M investment after merger plans unravel (American City Business Journals) -7.53%
06:50AM	TherapeuticsMD Announces $7 Million Private Placement (Business Wire)
Sep-12-22 06:50AM	TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers (Business Wire) +5.55%
Aug-15-22 01:00PM	TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript (Motley Fool)
08:05AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:50AM	TherapeuticsMD Announces Second Quarter 2022 Financial Results (Business Wire)
Aug-08-22 06:50AM	TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022 (Business Wire)
Aug-01-22 01:00PM	Pharma firm receives $15M investment after canceled merger (American City Business Journals) +36.60%
06:50AM	TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital (Business Wire)
Jul-15-22 01:34PM	HC Wainwright Rating & Price Target On TherapeuticsMD Under Review On 'Unclear Path' (Benzinga) +12.50%
Jul-13-22 09:48AM	Why TherapeuticsMD Shares Are Sinking Today? (Benzinga) -35.55%
08:25AM	TherapeuticsMD's stock falls 41% after tender offer expires (MarketWatch)
06:50AM	TherapeuticsMD Announces Expiration of Tender Offer (Business Wire)
Jul-06-22 06:09AM	EW Healthcare Partners Announces Extension of TherapeuticsMD Tender Offer (PR Newswire)
Jun-06-22 04:05PM	EW Healthcare Partners Announces Commencement of the Tender Offer for All Outstanding Shares of TherapeuticsMD (PR Newswire)
May-31-22 06:00AM	TherapeuticsMD and EW Healthcare Partners Announce Definitive Agreement for EW Healthcare Partners to acquire TherapeuticsMD (Business Wire) +364.02%
May-20-22 10:52AM	Why TherapeuticsMD Shares Are Trading Higher Today (Benzinga) +36.56%
09:43AM	TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA® (Business Wire)
May-16-22 08:00PM	TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call Transcript (Motley Fool) -14.01%
05:45PM	TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	TherapeuticsMD Announces First Quarter 2022 Financial Results (Business Wire)
May-12-22 05:25PM	Harpoon Therapeutics, Inc. (HARP) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -13.87%
May-10-22 04:05PM	TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022 (Business Wire) -24.78%
Apr-14-22 04:15PM	TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million (Business Wire)
Mar-10-22 01:30PM	TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call Transcript (Motley Fool) -27.50%
08:05AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
06:50AM	TherapeuticsMD Announces Fourth Quarter 2021 Financial Results (Business Wire)
Mar-07-22 12:57PM	TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal (Benzinga) +43.05%
07:40AM	TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx (Business Wire)
Mar-01-22 04:30PM	TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022 (Business Wire) -5.69%
Feb-28-22 05:35PM	Nektar Therapeutics (NKTR) Reports Q4 Loss, Lags Revenue Estimates (Zacks) +8.28%
Feb-24-22 09:05AM	Radius Health (RDUS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Jan-25-22 08:52AM	TherapeuticsMD, Inc. (NASDAQ:TXMD): Is Breakeven Near? (Simply Wall St.)
Jan-06-22 07:29AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
Jan-04-22 06:20AM	FDA Approves TherapeuticsMD's Low Dose Bijuva (Benzinga) +11.18%
Dec-28-21 09:53AM	Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options (Zacks)
Dec-13-21 06:08AM	TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits (Benzinga) -11.51%
Dec-10-21 04:30PM	U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA® (Business Wire)
Dec-08-21 06:50AM	TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) Allowing for a May 25, 2032 Generic Entry Date (Business Wire)
Nov-24-21 07:54AM	TherapeuticsMD (NASDAQ:TXMD) investors are sitting on a loss of 90% if they invested five years ago (Simply Wall St.)
Nov-22-21 10:40AM	Therapeuticsmd Insider Trades $580K In Company Stock (Benzinga)
Nov-12-21 03:00AM	TherapeuticsMD, Inc. (TXMD) Q3 2021 Earnings Call Transcript (Motley Fool)
Nov-11-21 06:50AM	TherapeuticsMD Announces Third Quarter 2021 Financial Results (Business Wire) -7.82%
06:45AM	TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh ODowd, as Chief Executive Officer (Business Wire)
Nov-04-21 03:01PM	TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-27-21 05:00PM	TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021 (Business Wire)
Oct-15-21 05:33PM	TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer (Business Wire)
Oct-05-21 01:28PM	What Type Of Shareholders Own The Most Number of TherapeuticsMD, Inc. (NASDAQ:TXMD) Shares? (Simply Wall St.)
Oct-04-21 09:20AM	Where Do Hedge Funds Stand On TherapeuticsMD Inc (TXMD)? (Insider Monkey)
Sep-02-21 06:50AM	Therapeutics MD Is Urging Women to Take Pause During Menopause Awareness Month (Business Wire) +7.71%
Aug-23-21 06:50AM	TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector (Business Wire) +7.12%
Aug-19-21 08:01AM	5 Penny Stocks Insiders Are Buying (Benzinga) +5.53%
Aug-09-21 04:30PM	TherapeuticsMD Announces Appointment of Hugh ODowd as President (Business Wire)
Aug-04-21 08:05AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.66%
06:50AM	TherapeuticsMD Announces Second Quarter 2021 Financial Results (Business Wire)
Jul-28-21 03:03PM	Will TherapeuticsMD (TXMD) Report Negative Earnings Next Week? What You Should Know (Zacks)
Jul-26-21 06:50AM	TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 (Business Wire)
Jul-06-21 11:49AM	10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman (Insider Monkey)
Jun-29-21 08:58AM	Breakeven On The Horizon For TherapeuticsMD, Inc. (NASDAQ:TXMD) (Simply Wall St.)
May-25-21 06:50AM	TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA (Business Wire)
May-24-21 07:00AM	The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award (Business Wire)
May-07-21 01:31AM	TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript (Motley Fool)
May-06-21 10:56AM	TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume (Benzinga) -13.28%
08:20AM	TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:00AM	TherapeuticsMD Announces First Quarter 2021 Financial Results (Business Wire)
06:45AM	TherapeuticsMD, Inc. to Host Earnings Call (ACCESSWIRE)
May-03-21 07:00AM	TherapeuticsMD Announces Poster Presentation of ANNOVERA® Data at the American College of Obstetricians and Gynecologists 2021 Annual Meeting (Business Wire)
Apr-29-21 10:34AM	TherapeuticsMD's (NASDAQ:TXMD) Shareholders Are Down 85% On Their Shares (Simply Wall St.)

TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thompson Tommy G	Director	Dec 23 '25	Buy	1.67	8,400	14,031	23,179	Dec 29 04:23 PM
Thompson Tommy G	Director	Apr 14 '25	Buy	1.00	325	326	14,779	Apr 15 07:59 AM
Walker Marlan D	Chief Executive Officer	Apr 14 '25	Buy	1.00	490	489	73,639	Apr 15 07:59 AM
Walker Marlan D	Chief Executive Officer	Apr 10 '25	Buy	0.86	1,167	1,000	73,149	Apr 10 04:29 PM
Walker Marlan D	Chief Executive Officer	Apr 09 '25	Buy	0.87	1,136	994	71,982	Apr 10 04:29 PM
Collins Cooper C.	Director	Feb 18 '25	Option Exercise	0.00	8,500	0	60,516	Feb 20 09:08 PM
Naughton Gail K	Director	Feb 18 '25	Option Exercise	0.00	8,500	0	8,500	Feb 20 09:07 PM
Thompson Tommy G	Director	Feb 18 '25	Option Exercise	0.00	8,500	0	14,454	Feb 20 09:07 PM
Walker Marlan D	Chief Executive Officer	Feb 18 '25	Option Exercise	0.00	8,281	0	70,846	Feb 20 09:07 PM

HELE

Helen of Troy Ltd

TXMD

TherapeuticsMD Inc

Upgrade your FINVIZ experience